Navigation Links
Thomson Reuters and the National Foundation for Cancer Research Provide Online Help for Cancer Patients
Date:4/22/2009

NexCura Cancer Profiler Tools Provide Patients with Treatment Information on www.nfcr.org

ANN ARBOR, Mich., April 22 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced today that it will incorporate NexCura(R) Cancer Profiler Tools from Thomson Reuters into its Web site.

The 20 online tools will provide cancer patients with critical, customized information about their treatment options.

"We are excited to provide a unique service like this to patients dealing with the stresses and questions that come with the diagnosis of cancer," said Franklin C. Salisbury, Jr., president of NFCR. "These tools empower cancer patients with the information they need but can't always easily find. These patients are under enough stress without having to experience difficulty in finding the information they need."

Alicia Moffat, vice president of Web operations for the Healthcare business of Thomson Reuters, explains: "The tools were created using patented technology that guides users through a step-by-step questionnaire to match the patient's diagnosis, diagnostic results, and disease stage with the relevant treatment options." All information provided by the NexCura Cancer Profiler Tools is peer-reviewed.

NFCR offers the NexCura Cancer Profiler under the Treatment Decision Tools section of its Web site (http://www.nfcr.org/patientsupport). The NexCura Cancer Profiler is the only online service generating comprehensive treatment information that is personalized for specific diagnoses and clinical status. The customized information enables patients to better communicate with their doctors and care teams and, through education, encourages the patient to play a more proactive role in treatment decisions.

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance and enhance the quality of healthcare. Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.

About NFCR

The National Foundation for Cancer Research has supported cutting-edge cancer research to advance personalized medicine and targeted therapies for over three decades. As a leading cancer charity, NFCR is dedicated to funding scientists who are discovering cancer's molecular mysteries and translating these discoveries into therapies that hold the hope for curing cancer. NFCR brings the most advanced medical resources to oncologists and health professionals to help guide their treatment decisions for patients worldwide. For more information, visit www.nfcr.org.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Thomson Acquires Prous Science
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. Thomson Scientific Ranks Australian Universities and Research Institutes
9. Thomson Scientific Launches Confessions ... of a User Campaign Asking Are You the New Face of Research?
10. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
11. Thomson Healthcare Launches Application That Assesses Physician Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: